The FoxC2 gene has been reported to have a higher expression in the claudin-low sub-type of triple-negative breast cancers compared with the basal sub-type and the luminal or Her2-overexpressing breast cancers [125]. This evidence concerns the gene ERBB2 and breast carcinoma.